| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.99B | 19.26B | 21.64B | 14.32B | 5.57B | 16.11B |
| Gross Profit | 8.35B | 8.06B | 3.84B | 4.86B | 2.01B | 6.90B |
| EBITDA | 9.97B | 7.13B | 9.17B | 9.50B | 1.35B | 14.98B |
| Net Income | 2.96B | 2.37B | 3.08B | 3.73B | -521.66M | 4.73B |
Balance Sheet | ||||||
| Total Assets | 412.08B | 410.14B | 360.10B | 317.29B | 275.35B | 264.29B |
| Cash, Cash Equivalents and Short-Term Investments | 9.32B | 6.16M | 112.56B | 108.57B | 12.82B | 10.09B |
| Total Debt | 54.85B | 54.77B | 50.82B | 49.39B | 44.07B | 39.59B |
| Total Liabilities | 331.28B | 328.51B | 298.11B | 258.92B | 219.98B | 206.15B |
| Stockholders Equity | 30.50B | 30.90B | 23.65B | 22.86B | 18.81B | 17.58B |
Cash Flow | ||||||
| Free Cash Flow | 6.89B | 9.52B | 6.51B | -1.60B | -5.36B | -7.28B |
| Operating Cash Flow | 7.06B | 9.68B | 6.65B | -1.49B | -5.28B | -7.18B |
| Investing Cash Flow | -9.97B | -13.06B | -19.05B | -3.88B | -13.65B | -9.61B |
| Financing Cash Flow | 3.94B | 5.01B | 7.08B | 12.77B | 22.06B | 20.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $176.18B | 16.88 | 11.52% | 1.92% | 22.84% | -3.04% | |
73 Outperform | $42.29B | 11.33 | 61.59% | 1.26% | 6.43% | 36.14% | |
70 Outperform | $144.00B | 34.66 | 36.16% | 3.02% | 17.79% | 17.92% | |
69 Neutral | $40.71B | 42.85 | 14.54% | 2.65% | 46.89% | 21.89% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $87.07B | 50.85 | 9.92% | 0.56% | 35.81% | 27.22% | |
58 Neutral | $17.29B | -32.87 | 9.65% | 2.30% | -26.37% | -49.86% |